The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Management of Cocaine Abuse and Dependence
Abstract
During the 20th century, there have been recurrent episodes of cocaine abuse in the United States that have achieved epidemic proportions.1 Although the total number of people using the drug has decreased in the past decade, cocaine-related biomedical and psychosocial problems remain a major public health problem in the United States and many other countries. The expanding list of cocaine-related toxic effects, acute and chronic, includes reproductive dysfunction, hepatic necrosis, and pulmonary disease.2 Abuse of and dependence on cocaine may also be associated with disorders of sexual function, sleep, anxiety, and mood, as well as with delirium and psychotic disorders. . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Persistent postwithdrawal disorders have been described with different classes of CNS drugs (e.g.protracted insomnia for alcohol and benzodiazepine withdrawal [10,36] and major depression/dysphoria for cocaine and amphetamine withdrawal [10,23] ), and even more so with specific drugs (e.g.quetiapine and paroxetine) within a drug class [6,15,16,33] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“We now have increasing evidence for postwithdrawal disorders with SSRI long-term use [6,15,16,26,37] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Data from controlled trials [15,20,29] , case reports [16] , and online patient reports [26] show that paroxetine is most likely to be associated with new withdrawal symptoms, and fluoxetine the least.”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“According to most studies [1,15,16,20,29] , even with gradual tapering, withdrawal symptoms still occur.”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Fava et al. [16] conducted a study of gradual SSRI discontinuation in panic disorder and found that 9 of 20 patients (45%) experienced new withdrawal symptoms, and that 3 of the 9 (33%) patients treated with paroxetine had postwithdrawal disorders at 1 year of follow-up, including bipolar spectrum disorder (n = 2) and major depressive disorder (n = 1).”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“They may resemble rebound symptoms being more severe than the original symptoms, but these disorders persist at least 6 weeks in contrast to rebound symptoms and [6,15,16,26,37] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Persistent postwithdrawal panic disorder [15,38] has been shown to occur following withdrawal of paroxetine, and paroxetine has also been associated with other postwithdrawal disorders [6,15,16] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients
McLellan, A. T., Luborsky, L. B., WOODY, G. E., & Brien, C. P. O. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,163
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Naltrexone and Coping Skills Therapy for Alcohol Dependence
O’Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,476
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,143
The dopamine hypothesis of the reinforcing properties of cocaine
Kuhar, M. J., Ritz, M. C., & Boja, J. W. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90141-g · Cited by 1,005
Gawin, F. H., & Ellinwood, E. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181806 · Cited by 965
Research works printed but not linked: 22
- Musto DF. The American disease: origins of narcotic control. New Haven, Conn.: Yale University Press, 1973.
- Mendelson JH, Mello NK. Cocaine and other commonly abused drugs. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994:2429-33.
- National Institute on Drug Abuse. Epidemiologic trends in drug abuse. Vol. 1. Highlights and executive summary. Washington, D.C.: Government Printing Office, 1995. (NIH publication no. 95-3988.)
- Johanson CE, 1989, Pharmacol Rev, 41, 3
- Foltin RW, 1991, J Pharmacol Exp Ther, 257, 247
- McCance EF, 1995, J Pharmacol Exp Ther, 274, 215
- Holman BL, 1991, J Nucl Med, 32, 1206
- Gawin FH, 1988, J Clin Psychiatry, 49, 11
- Millman R, 1988, J Clin Psychiatry, 49, 27
- Mendelson JH, 1992, J Pharmacol Exp Ther, 263, 505
- Mello NK, 1990, J Pharmacol Exp Ther, 254, 815
- Mello NK, 1993, J Pharmacol Exp Ther, 266, 804
- Covi L, 1994, Clin Pharmacol Ther, 55, 132
- Kosten TR, 1987, J Clin Psychiatry, 48, 442
- Kuhar MJ, 1993, Pharmacologist, 35, 28
- Kosten TR, 1988, Am J Psychiatry, 145, 381
- Preston KL, 1993, J Pharmacol Exp Ther, 267, 296
- Kreek MJ. Multiple drug abuse patterns and medical consequences. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1597-604.
- Mendelson JH, Albeck J. Naloxone modification of acute alcohol intoxication in humans. In: Proceedings of the 39th Annual Scientific Meeting, Committee on Problems of Drug Dependence, Cambridge, Mass, July 1977. Washington, D.C.: Committee on Problems of Drug Dependence, 1978:572-82.
- Mendelson JH, 1992, Neuropsychopharmacology, 7, 157
- Gastfriend DR, 1993, Am J Addict, 2, 269
- Gastfriend DR, Mendelson JH, Mello NK, et al. Longitudinal dose comparisons of buprenorphine for combined opiate and cocaine dependence. In: Harris LS, ed. Problems of drug dependence, 1995: proceedings of the 57th Annual Scientific Meeting, the Committee on Problems of Drug Dependence, Inc. NIDA research monograph. Washington, D.C.: Government Printing Office (in press).
Cited by
Sorted by citations
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880
Arousal and reward: a dichotomy in orexin function
Harris, G. C., & Aston‐Jones, G. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.08.002 · Cited by 567
Management of Drug and Alcohol Withdrawal
Kosten, T. R., & O'Connor, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020617 · Cited by 563
Neuroplasticity in the mesolimbic dopamine system and cocaine addiction
Thomas, M. J., Kalivas, P. W., & Shaham, Y. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.77 · Cited by 521
Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477
Incubation of cocaine craving after withdrawal: a review of preclinical data
Lü, L., Grimm, J. W., Hope, B. T., & Shaham, Y. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.027 · Cited by 443
N-Acetylcysteine reverses cocaine-induced metaplasticity
Moussawi, K., Pacchioni, A. M., Moran, M., Olive, M. F., Gass, J. T., Lavín, A., & Kalivas, P. W. (2009) · Nature Neuroscience · doi:10.1038/nn.2250 · Cited by 403
Mello, N. K. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00274-h · Cited by 391
Self-citationThe Role of Orbitofrontal Cortex in Drug Addiction: A Review of Preclinical Studies
Schoenbaum, G. M., & Shaham, Y. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.003 · Cited by 323
Crack Cocaine and Cocaine Hydrochloride
Hatsukami, D. K. (1996) · JAMA · doi:10.1001/jama.1996.03540190052029 · Cited by 306
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477313 · Cited by 270
The validity of the reinstatement model of craving and relapse to drug use
Katz, J. L., & Higgins, S. T. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1441-y · Cited by 273
Neurobiology of relapse to heroin and cocaine seeking: An update and clinical implications
Bossert, J. M., Ghitza, U. E., Lü, L., Epstein, D. H., & Shaham, Y. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.030 · Cited by 271
Wen, Y., Pei, H., Wan, Y., Su, Y. L., Huang, Q., Song, S., & Fan, C. (2011) · Analytical Chemistry · doi:10.1021/ac201491p · Cited by 265
Caine, S. B., Negus, S. S., Mello, N. K., Patel, S., Bristow, L., Kulagowski, J., Vallone, D., Saiardi, A., & Borrelli, E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02977.2002 · Cited by 234
Self-citationToxicity of local anaesthetics
Cox, B., Durieux, M. E., & Marcus, M. A. E. (2003) · Best practice & research. Clinical anaesthesiology · doi:10.1053/bean.2003.0275 · Cited by 228
The impact of orbitofrontal dysfunction on cocaine addiction
Lucantonio, F., Stalnaker, T. A., Shaham, Y., Niv, Y., & Schoenbaum, G. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3014 · Cited by 219
Community Reinforcement Therapy for Cocaine-Dependent Outpatients
Higgins, S. T., Sigmon, S. C., Wong, C. J., Heil, S. H., Badger, G. J., Donham, R., Dantona, R. L., & Anthony, S. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.1043 · Cited by 205
Pharmacotherapies for Treatment of Cocaine Abuse: Preclinical Aspects
Carroll, F. I., Howell, L. L., & Kuhar, M. J. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9706729 · Cited by 202
Higgins, S. T., Alessi, S. M., & Dantona, R. L. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(02)00297-6 · Cited by 202
Computational redesign of human butyrylcholinesterase for anticocaine medication
Pan, Y., Gao, D., Yang, W., Cho, H., Yang, G., Tai, H., & Zhan, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507332102 · Cited by 185
Lack of Self-Administration of Cocaine in Dopamine D 1 Receptor Knock-Out Mice
Caine, S. B., Thomsen, M., Gabriel, K. I., Berkowitz, J. S., Gold, L. H., Koob, G. F., Tonegawa, S., Zhang, J., & Xu, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2284-07.2007 · Cited by 183
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 188
Wilbert-Lampen, U., Seliger, C., Zilker, T. R., & Arendt, R. (1998) · Circulation · doi:10.1161/01.cir.98.5.385 · Cited by 179
Most Efficient Cocaine Hydrolase Designed by Virtual Screening of Transition States
Zheng, F., Yang, W., Ko, M., Liu, J., Cho, H., Gao, D., Tong, M., Tai, H., Woods, J. H., & Zhan, C. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803646t · Cited by 176
Pharmacological and Environmental Determinants of Relapse to Cocaine-Seeking Behavior
Spealman, R. D., Barrett-Larimore, R. L., Rowlett, J. K., Platt, D. M., & Khroyan, T. V. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00049-0 · Cited by 173
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
Bravo, R. R., Faria, A. C., Brito-da-Costa, A. M., Carmo, H., Mladěnka, P., da Silva, D. D., Remião, F., & Researchers, O. B. O. T. O. (2022) · Toxins · doi:10.3390/toxins14040278 · Cited by 163
Crombag, H. S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00356-1 · Cited by 155
Effects of Dopamine D1-like and D2-likeAgonists in Rats that Self-Administer Cocaine
Caine, S. B., Negus, S. S., Mello, N. K., & Bergman, J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35108-0 · Cited by 151
Self-citationReactivity to laboratory stress provocation predicts relapse to cocaine
Back, S. E., Hartwell, K., DeSantis, S. M., Saladin, M., McRae-Clark, A. L., Price, K. L., Moran-Santa Maria, M. M., Baker, N. L., Spratt, E., Kreek, M. J., et al. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.07.016 · Cited by 148
Interactions between Kappa Opioid Agonists and Cocaine: Preclinical Studies
Mello, N. K., & Negus, S. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06678.x · Cited by 145
Self-citationEffects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys
Mello, N. K., & Negus, S. S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37657-8 · Cited by 141
Self-citationLoweth, J. A., Tseng, K. Y., & Wolf, M. E. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.061 · Cited by 142
How to make a rat addicted to cocaine
Roberts, D. C. S., Morgan, D., & Liu, Y. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.028 · Cited by 143
Cocaine’s Effects on Neuroendocrine Systems: Clinical and Preclinical Studies
Mello, N. K., & Mendelson, J. H. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00433-9 · Cited by 133
Self-citationWang, J., Fang, Q., Liu, Z., & Lu, L. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0262-6 · Cited by 134
Grimm, J. W., Shaham, Y., & Hope, B. T. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00011 · Cited by 131
D3 receptor test in vitro predicts decreased cocaine self-administration in rats
Caine, S. B., Koob, G. F., Parsons, L. H., Everitt, B. J., Schwartz, J.-C., & Sokoloff, P. (1997) · Neuroreport · doi:10.1097/00001756-199707070-00054 · Cited by 130
Li, Z., Zhao, B., Wang, D., Wen, Y., Liu, G., Dong, H., Song, S., & Fan, C. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am5047735 · Cited by 125
Effect of a selective dopamine D 1 agonist (ABT-431) on smoked cocaine self-administration in humans
Haney, M., Collins, E. D., Ward, A. S., Foltin, R. W., & Fischman, M. W. (1999) · Psychopharmacology · doi:10.1007/s002130050925 · Cited by 121
Negus, S. S., & Mello, N. K. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00339-3 · Cited by 120
Self-citationA Label-Free Aptamer-Fluorophore Assembly for Rapid and Specific Detection of Cocaine in Biofluids
Roncancio, D., Yu, H., Xu, X., Wu, S., Liu, R., DeBord, J., Lou, X., & Xiao, Y. (2014) · Analytical Chemistry · doi:10.1021/ac503360n · Cited by 117
Fletcher, P. J., Rizos, Z., Sinyard, J., Tampakeras, M., & Higgins, G. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301509 · Cited by 114
Howell, L. L., & Wilcox, K. M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29344-7 · Cited by 115
Manchikanti, L. (2004) · Pain Physician · doi:10.36076/ppj.2004/7/431 · Cited by 113
Treating cocaine addiction with viruses
Carrera, M. R. A., Kaufmann, G. F., Mee, J. M., Meijler, M. M., Koob, G. F., & Janda, K. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403795101 · Cited by 110
Jacobsen, L. K., Staley, J. K., Malison, R. T., Zoghbi, S. S., Seibyl, J. P., Kosten, T. R., & Innis, R. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1134 · Cited by 110
Guzman, N. A., Park, S. S., Schaufelberger, D. E., Hernandez, L., Páez, X., Rada, P. V., Tomlinson, A. J., & Naylor, S. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00275-2 · Cited by 109
Oxytocin in learning and addiction: From early discoveries to the present
Sarnyai, Z., & Kovács, G. L. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.019 · Cited by 110
Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development
Platt, D. M., Rowlett, J. K., & Spealman, R. D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1137-8 · Cited by 107
A conflict rat model of cue-induced relapse to cocaine seeking
Cooper, A., Barnea‐Ygael, N., Levy, D. J., Shaham, Y., & Zangen, A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0827-7 · Cited by 105
An overview of non-cardiac cocaine toxicity
Glauser, J. M., & Queen, J. R. (2007) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2006.05.044 · Cited by 102
Hando, J., Topp, L., & Hall, W. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00051-3 · Cited by 101
Negus, S. S., & Mello, N. K. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1409-y · Cited by 101
Self-citationMechanisms of transgenerational inheritance of addictive-like behaviors
Vassoler, F. M., & Sadri-Vakili, G. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.064 · Cited by 96
Cardiovascular disorders associated with cocaine use: myths and truths
Knuepfer, M. M. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00329-7 · Cited by 94
Gender and stimulus difference in cue-induced responses in abstinent heroin users
Yu, J., Zhang, S., Epstein, D. H., Fang, Y., Shi, J., Qin, H., Yao, S.-J., Foll, B. L., & Lü, L. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.01.008 · Cited by 94
Huang, X., Gu, H. H., & Zhan, C. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp900963n · Cited by 93
How Dopamine Transporter Interacts with Dopamine: Insights from Molecular Modeling and Simulation
Huang, X., & Zhan, C. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.110924 · Cited by 90
Froimowitz, M., Wu, K.-M., Moussa, A. M., Haidar, R. M., Jurayj, J., George, C. F., & Gardner, E. L. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000201d · Cited by 88
Thermostable Variants of Cocaine Esterase for Long-Time Protection against Cocaine Toxicity
Gao, D., Narasimhan, D. L., Macdonald, J., Brim, R. L., Ko, M., Landry, D. W., Woods, J. H., Sunahara, R. K., & Zhan, C. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049486 · Cited by 89
Irwin, M. R., Olmos, L., Wang, M., Valladares, E. M., Motivala, S. J., Fong, T., Newton, T., Butch, A. W., Olmstead, R., & Cole, S. W. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112797 · Cited by 88
Feldman, J. A., Fish, S. S., Beshansky, J. R., Griffith, J. L., Woolard, R. H., & Selker, H. P. (2000) · Annals of Emergency Medicine · doi:10.1067/mem.2000.110994 · Cited by 88
Baumann, M. H., & Rothman, R. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00123-1 · Cited by 87
Recent trends in drug abuse in China1
Fang, Y., Yan-bo, W. A. N. G., Shi, J., Liu, Z., & Lü, L. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00270.x · Cited by 85
Highfield, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00227-5 · Cited by 81
Epigenetics and Psychostimulant AddictionPreprint
Schmidt, H. D., McGinty, J. F., West, A. E., & Sadri‐Vakili, G. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012047 · Cited by 82
Mendelson, J. H., Sholar, M. B., Mutschler, N. H., Jaszyna-Gasior, M., Goletiani, N. V., Siegel, A. J., & Mello, N. K. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052928 · Cited by 81
Self-citationCurcio, L., Podda, M. V., Leone, L., Piacentini, R., Mastrodonato, A., Cappelletti, P., Sacchi, S., Pollegioni, L., Grassi, C., & D’Ascenzo, M. (2013) · Brain · doi:10.1093/brain/awt036 · Cited by 79
Forced Abstinence Model of Relapse to Study Pharmacological Treatments of Substance Use Disorder
Reichel, C. M., & Bevins, R. A. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902020184 · Cited by 79
Panlilio, L. V., Goldberg, S. R., Gilman, J. P., Jufer, R. A., Cone, E. J., & Schindler, C. W. (1998) · Psychopharmacology · doi:10.1007/s002130050618 · Cited by 79
Johnson, B., Roache, J. D., Ait‐Daoud, N., Javors, M. A., Harrison, J. K., Elkashef, A. M., Mojsiak, J., Li, S., & Bloch, D. A. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.02.011 · Cited by 78
Couto, B. R. D., Aguilar, M. A., Manzanedo, C., Rodríguez‐Arias, M., & Miñarro, J. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.10.005 · Cited by 77
Pan, Y., Gao, D., Yang, W., Cho, H., & Zhan, C. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073724k · Cited by 77
Lu, H., Chen, X., & Zhan, C. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp072917r · Cited by 75
Gao, D., Cho, H., Yang, W., Pan, Y., Yang, G., Tai, H., & Zhan, C. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200503025 · Cited by 75
Barker, D., Simmons, S. J., & West, M. O. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13999150318113642 · Cited by 72
Caine, S. B., Negus, S. S., & Mello, N. K. (2000) · Psychopharmacology · doi:10.1007/s002130050023 · Cited by 73
Self-citationAuricular Acupuncture in the Treatment of Cocaine Abuse
Bullock, M. L., Kiresuk, T. J., Pheley, A. M., Culliton, P. D., & Lenz, S. K. (1999) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(98)00002-6 · Cited by 72
Bowen, C. A., Negus, S. S., Zong, R., Neumeyer, J. L., Bidlack, J. M., & Mello, N. K. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300105 · Cited by 72
Self-citationHigley, A. E., Kiefer, S. W., Li, X., Gaál, J., Xi, Z., & Gardner, E. L. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.02.046 · Cited by 70
Characterization of a high-activity mutant of human butyrylcholinesterase against (−)-cocaine
Yang, W., Liu, X., Fang, L., Chen, X., & Zhan, C. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.01.004 · Cited by 69
Chauvet, C., Lardeux, V., Jaber, M., & Solinas, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.068 · Cited by 68
Cocaine and Psychiatric Symptoms
Morton, W. A. (1999) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v01n0403 · Cited by 68
Implications of an animal model of sugar addiction, withdrawal and relapse for human health
Wideman, C. H., Nadzam, G. R., & Murphy, H. M. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500485221 · Cited by 67
Cocaine use, hypertension, and end-stage renal disease
Norris, K. C., Thornhill-Joynes, M., Robinson, C., Strickland, T. L., Alperson, B. L., Witana, S. C., & Ward, H. J. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.26845 · Cited by 67
Lü, L., Dempsey, J., Shaham, Y., & Hope, B. T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03178.x · Cited by 65
Rapid and Persistent Sensitization to the Reinforcing Effects of Cocaine
Morgan, D., Liu, Y., & Roberts, D. C. S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300773 · Cited by 62
Filip, M., & Frankowska, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.069 · Cited by 63
Kalirin, a Key Player in Synapse Formation, Is Implicated in Human Diseases
Mandela, P., & Ma, X. (2012) · Neural Plasticity · doi:10.1155/2012/728161 · Cited by 65
PG01037, a novel dopamine D 3 receptor antagonist, inhibits the effects of methamphetamine in rats
Higley, A. E., Spiller, K. J., Grundt, P., Newman, A. H., Kiefer, S. W., Xi, Z., & Gardner, E. L. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109358201 · Cited by 63
Highfield, D. A., Mead, A. N., Grimm, J. W., Rocha, B. A. G., & Shaham, Y. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1047-9 · Cited by 61
Shi, Y. C., Dai, H., Sun, Y., Hu, J., Ni, P., & Li, Z. (2013) · The Analyst · doi:10.1039/c3an00897e · Cited by 60
Free-Energy Perturbation Simulation on Transition States and Redesign of Butyrylcholinesterase
Yang, W., Pan, Y., Zheng, F., Cho, H., Tai, H., & Zhan, C. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.11.051 · Cited by 60
Jones, A. W., Holmgren, A., & Kugelberg, F. C. (2008) · Forensic Science International · doi:10.1016/j.forsciint.2007.11.009 · Cited by 58
Social cognition and interaction in stimulant use disorders
Quednow, B. B. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.10.001 · Cited by 58
Temporal concordance of cocaine effects on mood states and neuroendocrine hormones
Mendelson, J. H., Mello, N. K., Sholar, M. B., Siegel, A. J., Mutschler, N. H., & Halpern, J. H. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00036-1 · Cited by 58
Self-citationPHARMACOTHERAPY FOR OPIOID AND COCAINE ABUSE
Warner, E. A., Kosten, T. R., & O’Connor, P. G. (1997) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70555-1 · Cited by 56
Reinstatement of Morphine‐Induced ConditionedPlace Preference in Mice by Priming Injections
Couto, B. R. D., Aguilar, M. A., Manzanedo, C., Rodríguez‐Arias, M., & Miñarro, J. (2003) · Neural Plasticity · doi:10.1155/np.2003.279 · Cited by 55
Metadata
- Authors
- Mendelson, J. H., & Mello, N. K.
- Affiliations
- Harvard University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1996-04-11
- Volume
- 334
- Issue
- 15
- Pages
- 965-972
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338649220
- Cited by
- 291
- References
- 112
- Citations by year
- 2024: 4 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 8 · 2015: 7 · 2014: 9 · 2013: 20 · 2012: 14
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r18da006116-05)
- National Institute on Drug Abuse (DA 06116, K05DA000064, KO5-DA 00101, KO5 DA 00064, K05DA000101)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Youth, Drugs, and Violence
- Keywords
- cocaine abuse, cocaine dependence, cocaine toxicity, reproductive disorders, liver necrosis, lung disease, sexual dysfunction, sleep disorders, anxiety, mood disorders, delirium, psychosis
- MeSH terms
- Antidepressive Agents, Carbamazepine, Cocaine, Humans, Narcotic Antagonists, Narcotics, Dopamine Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
